President Trump’s nominee to lead the Food and Drug Administration (FDA), Dr. Heidi Overton, testifies in a Senate confirmation hearing aimed at determining whether she will be confirmed to head the agency. The hearing is scheduled before the Senate Committee on Health, Education, Labor and Pensions (HELP).
Both outlets report that the session includes questions expected to focus on Overton’s views and experience related to vaccines and other public health issues. The Hill describes Overton as a White House domestic policy aide and a preventive medicine physician, setting expectations for scrutiny of her qualifications and approach to FDA responsibilities. STAT similarly reports that Overton is expected to face questions during the hearing and notes coverage will be delivered via a live blog, but it does not add additional substantive detail beyond the hearing itself.
Taken together, the reports focus on the same core event: Overton appears before the HELP Committee as part of the Senate’s confirmation process to become FDA commissioner.
